SER (STOCKS)
Serina Therapeutics, Inc.
$2.000000
+0.020000 (+1.01%)
Prev close: $1.980000
Company Information
- Exchange
- XASE
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- CEO
- Steven A. Ledger
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $24.01M
- Employees
- 13
- P/E (TTM)
- -1.03
- P/B (TTM)
- -4.24
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $130.00K |
| Benefits Costs and Expenses | $19.33M |
| Costs And Expenses | $19.33M |
| Nonoperating Income/Loss | $4.83M |
| Operating Expenses | $24.15M |
| Depreciation and Amortization | $73.00K |
| Research and Development | $13.16M |
| Other Operating Expenses | $10.92M |
| Operating Income/Loss | -$24.02M |
| Income/Loss From Continuing Operations After Tax | -$19.22M |
| Income/Loss From Continuing Operations Before Tax | -$19.20M |
| Income Tax Expense/Benefit | $18.00K |
| Net Income/Loss | -$19.22M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$33.00K |
| Net Income/Loss Attributable To Parent | -$19.18M |
| Net Income/Loss Available To Common Stockholders, Basic | -$19.44M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $254.00K |
| Preferred Stock Dividends And Other Adjustments | $254.00K |
| Basic Earnings Per Share | -$1.91 |
| Diluted Earnings Per Share | -$1.91 |
| Basic Average Shares | 10,190,000 |
| Diluted Average Shares | 10,190,000 |
| Assets | $6.95M |
| Current Assets | $6.08M |
| Noncurrent Assets | $871.00K |
| Fixed Assets | $465.00K |
| Other Non-current Assets | $406.00K |
| Liabilities | $6.99M |
| Current Liabilities | $3.56M |
| Accounts Payable | $1.93M |
| Other Current Liabilities | $1.63M |
| Noncurrent Liabilities | $3.43M |
| Equity | -$37.00K |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$37.00K |
| Liabilities And Equity | $6.95M |
| Net Cash Flow From Operating Activities | -$17.96M |
| Net Cash Flow From Operating Activities, Continuing | -$17.96M |
| Net Cash Flow From Investing Activities | -$59.00K |
| Net Cash Flow From Investing Activities, Continuing | -$59.00K |
| Net Cash Flow From Financing Activities | $17.41M |
| Net Cash Flow From Financing Activities, Continuing | $17.41M |
| Net Cash Flow | -$602.00K |
| Net Cash Flow, Continuing | -$602.00K |
| Comprehensive Income/Loss | -$19.23M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | -$33.00K |
| Comprehensive Income/Loss Attributable To Parent | -$19.20M |
| Other Comprehensive Income/Loss | -$14.00K |